Consistent with a previous report that targeted BRAF inhibition in melanoma activates stromal fibroblasts [53], a comparison of ECM organization in the same patient prior to therapy and post-therapy indicated that when the treatment is failing, matrix alignment increases and curvature and fractal dimension decrease (S10 Fig). The gene discussed is BRAF; the disease is melanoma.